![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Vaccines |
Free Subscription
1 AIDS |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Vaccines is free of charge.
High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated
with BNT162b2.
AIDS. 2022 Jun 23. pii: 00002030-990000000-00043.
PubMed
Abstract available
COVID-19 exit strategy during vaccine implementation: a balance between social
distancing and herd immunity.
Arch Virol. 2022 Jun 20. pii: 10.1007/s00705-022-05495.
PubMed
Abstract available
Covid-19: UK makes first payments to compensate injury or death from vaccines.
BMJ. 2022;377:o1565.
PubMed
Moderna to open mRNA vaccine research and manufacturing centre in the UK.
BMJ. 2022;377:o1556.
PubMed
Monkeypox: Gay and bisexual men with high exposure risk will be offered vaccine
in England.
BMJ. 2022;377:o1542.
PubMed
Characterising the background incidence rates of adverse events of special
interest for covid-19 vaccines in eight countries: multinational network cohort
study.
BMJ. 2021;373:n1435.
PubMed
Abstract available
Covid-19: CDC and FDA approve Pfizer and Moderna vaccines for under 5s.
BMJ. 2022;377:o1507.
PubMed
Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation
to the timing of antenatal vaccination.
Clin Infect Dis. 2022 Jun 19. pii: 6611486. doi: 10.1093.
PubMed
Abstract available
Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare
workers - Mexico, March-December 2021.
Clin Infect Dis. 2022 Jun 19. pii: 6611492. doi: 10.1093.
PubMed
Abstract available
Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing
Interval for ChAdOx1 nCoV-19 Vaccine.
Clin Infect Dis. 2022 Jun 20. pii: 6611567. doi: 10.1093.
PubMed
Abstract available
SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof
of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021.
Clin Infect Dis. 2022 Jun 20. pii: 6611550. doi: 10.1093.
PubMed
Abstract available
Hospitalized patients with severe COVID-19 during the Omicron wave in Israel -
benefits of a fourth vaccine dose.
Clin Infect Dis. 2022 Jun 20. pii: 6611845. doi: 10.1093.
PubMed
Abstract available
COVID-19 vaccination coverage, intentions, attitudes and barriers by
race/ethnicity, language of interview, and nativity, National Immunization Survey
Adult COVID Module, April 22, 2021-January 29, 2022.
Clin Infect Dis. 2022 Jun 23. pii: 6614630. doi: 10.1093.
PubMed
Abstract available
Perinatally HIV-infected adolescents and young adults demonstrate distinct
BNT162b2 mRNA COVID-19 vaccine immunogenicity.
Clin Infect Dis. 2022 Jun 23. pii: 6615389. doi: 10.1093.
PubMed
Abstract available
Why We Need Precision Vaccinology.
Clin Infect Dis. 2022 Jun 23. pii: 6615391. doi: 10.1093.
PubMed
The US COVID-19 surveillance environment: An ecological analysis of the
relationship of testing adequacy in the context of vaccination.
Clin Infect Dis. 2022 Jun 24. pii: 6617111. doi: 10.1093.
PubMed
Abstract available
Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health
Response through Partnerships and Collaborations.
Clin Infect Dis. 2022 Jun 24. pii: 6617337. doi: 10.1093.
PubMed
Abstract available
Advancing Precision Vaccinology by Molecular and Genomic Surveillance of
SARS-CoV-2 in Germany, 2021.
Clin Infect Dis. 2022 Jun 25. pii: 6617635. doi: 10.1093.
PubMed
Abstract available
Development of Two Mouse Models for Vaccine Evaluation against Cryptosporidiosis.
Infect Immun. 2022 Jun 23:e0012722. doi: 10.1128/iai.00127.
PubMed
Abstract available
Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with
Molecular Adjuvant Adenosine Deaminase-1.
J Immunol. 2022 Jun 24. pii: jimmunol.2200056. doi: 10.4049/jimmunol.2200056.
PubMed
Abstract available
Safety and immunogenicity of the inactivated whole-virus adjuvanted vaccine
VLA2001: a randomized, dose escalation, double-blind phase 1/2 clinical trial in
healthy adults.
J Infect. 2022 Jun 16. pii: S0163-4453(22)00361.
PubMed
Abstract available
Rotavirus Disease and Genotype Diversity in Older Children and Adults in
Australia.
J Infect Dis. 2022;225:2116-2126.
PubMed
Abstract available
Vaccination after SARS-CoV-2 infection increased antibody avidity against the
Omicron variant compared to vaccination alone.
J Infect Dis. 2022 Jun 18. pii: 6609994. doi: 10.1093.
PubMed
Abstract available
High neutralizing antibody levels against SARS-CoV-2 Omicron BA.1 and BA.2 after
UB-612 vaccine booster.
J Infect Dis. 2022 Jun 20. pii: 6611838. doi: 10.1093.
PubMed
Abstract available
Omicron breakthrough infection after heterologous prime-boost vaccination induces
a vigorous antibody response.
J Infect Dis. 2022 Jun 20. pii: 6611839. doi: 10.1093.
PubMed
Abstract available
Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines
RSV/DeltaNS2/Delta1313/I1314L and RSV/276 in RSV Seronegative Children.
J Infect Dis. 2022 Jun 23. pii: 6613410. doi: 10.1093.
PubMed
Abstract available
Decreased antibody response after SARS-CoV-2 vaccination in patients with Down
Syndrome.
J Infect Dis. 2022 Jun 24. pii: 6617441. doi: 10.1093.
PubMed
Abstract available
HPV vaccination associated with decreased cervical cancer incidence and
mortality.
J Pediatr. 2022;245:246-249.
PubMed
BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust
Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
J Virol. 2022;96:e0052822.
PubMed
Abstract available
COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal
Antibodies.
JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.
PubMed
mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
JAMA. 2022;327:2280.
PubMed
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During
Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
MMWR Morb Mortal Wkly Rep. 2022;71:786-790.
PubMed
Abstract available
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
N Engl J Med. 2022;386:2345-2346.
PubMed
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
Reply.
N Engl J Med. 2022;386:2346.
PubMed
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.
N Engl J Med. 2022;386:2441.
PubMed
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. Reply.
N Engl J Med. 2022;386:2441-2442.
PubMed
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.
N Engl J Med. 2022;386:2377-2386.
PubMed
Abstract available
Audio Interview: Vaccinating Young Children against Covid-19.
N Engl J Med. 2022;386:e77.
PubMed
Covid-19 Vaccination during Pregnancy - Two for the Price of One.
N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMe2206730.
PubMed
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMoa2204399.
PubMed
Abstract available
Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy.
N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2205276.
PubMed
Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection
with SARS-CoV-2 variants by analysis of genetic distance.
Nat Med. 2022 Jun 16. pii: 10.1038/s41591-022-01877.
PubMed
Abstract available
A randomized controlled trial to test financial incentives for COVID-19
vaccination in Ghana.
Nat Med. 2022 Jun 16. pii: 10.1038/s41591-022-01876.
PubMed
Human Papillomavirus Vaccination Trends Among Adolescents: 2015 to 2020.
Pediatrics. 2022 Jun 22. pii: 188308. doi: 10.1542/peds.2022-056597.
PubMed
Abstract available
COVID-19 Vaccines in Infants, Children, and Adolescents.
Pediatrics. 2022 Jun 18. pii: 188297. doi: 10.1542/peds.2022-058700.
PubMed
Abstract available
Vaccine Effectiveness of BNT162b2 Against Delta and Omicron Variants in
Adolescents.
Pediatrics. 2022 Jun 16. pii: 188277. doi: 10.1542/peds.2022-057634.
PubMed
Abstract available
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers
in the Sisonke study in South Africa: A phase 3b implementation trial.
PLoS Med. 2022;19:e1004024.
PubMed
Abstract available
Adverse events of special interest and mortality following vaccination with mRNA
(BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A
retrospective study.
PLoS Med. 2022;19:e1004018.
PubMed
Abstract available
Association of pneumococcal carriage in infants with the risk of carriage among
their contacts in Nha Trang, Vietnam: A nested cross-sectional survey.
PLoS Med. 2022;19:e1004016.
PubMed
Abstract available
Temporal changes in spike IgG levels after two doses of BNT162b2 vaccine in
Japanese healthcare workers: Do spike IgG levels at 3 months predict levels 6 or
8 months after vaccination?
PLoS One. 2022;17:e0263486.
PubMed
Abstract available
Correction: Reasons for nonadherence to vaccination for influenza among older
people in Brazil.
PLoS One. 2022;17:e0270443.
PubMed
Abstract available
Analyzing COVID-19 disinformation on Twitter using the hashtags #scamdemic and
#plandemic: Retrospective study.
PLoS One. 2022;17:e0268409.
PubMed
Abstract available
Healthcare provider perspectives on delivering next generation rotavirus vaccines
in five low-to-middle-income countries.
PLoS One. 2022;17:e0270369.
PubMed
Abstract available
Role of literacy, fear and hesitancy on acceptance of COVID-19 vaccine among
village health volunteers in Thailand.
PLoS One. 2022;17:e0270023.
PubMed
Abstract available
Neutralizing antibodies levels are increased in individuals with heterologous
vaccination and hybrid immunity with Ad5-nCoV in the north of Mexico.
PLoS One. 2022;17:e0269032.
PubMed
Abstract available
The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni
Mohammed memorial comprehensive specialized hospital health workers. Cross
sectional survey.
PLoS One. 2022;17:e0265140.
PubMed
Abstract available
Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization
(DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection.
PLoS One. 2022;17:e0270060.
PubMed
Abstract available
Assessment of attitude towards COVID-19 vaccine and associated factors among
clinical practitioners in Ethiopia: A cross-sectional study.
PLoS One. 2022;17:e0269923.
PubMed
Abstract available
Identification of the Bartonella autotransporter CFA as a protective antigen and
hypervariable target of neutralizing antibodies in mice.
Proc Natl Acad Sci U S A. 2022;119:e2202059119.
PubMed
Abstract available
Opsonophagocytic activity against Streptococcus pneumoniae in Indigenous and
non-Indigenous patients with severe chronic kidney disease immunized with
13-valent pneumococcal conjugate vaccine.
Vaccine. 2022 Jun 20. pii: S0264-410X(22)00810.
PubMed
Abstract available
Safety and protective capability of an inactivated SARS-CoV-2 vaccine on
pregnancy, lactation and the growth of offspring in hACE2 mice.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00765.
PubMed
Abstract available
BCG vaccine safety in COVID-19 convalescent adults: BATTLE a randomized
controlled trial.
Vaccine. 2022 Jun 20. pii: S0264-410X(22)00803.
PubMed
Abstract available
Oral vaccine formulation combining tick Subolesin with heat inactivated
mycobacteria provides control of cross-species cattle tick infestations.
Vaccine. 2022 Jun 18. pii: S0264-410X(22)00804.
PubMed
Abstract available
Previous biological therapy and impairment of the IFN-gamma/IL-10 axis are
associated with low immune response to 17DD-YF vaccination in patients with
spondyloarthritis.
Vaccine. 2022 Jun 18. pii: S0264-410X(22)00703.
PubMed
Abstract available
Estimating the number of US children susceptible to measles resulting from
COVID-19-related vaccination coverage declines.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00782.
PubMed
Abstract available
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1:
Standardized template with key considerations for a risk/benefit assessment.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00755.
PubMed
Abstract available
A Brighton Collaboration standardized template with key considerations for a
benefit/risk assessment for an inactivated viral vaccine against Chikungunya
virus.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00753.
PubMed
Abstract available
Safety of COVID-19 vaccination and acute neurological events: A self-controlled
case series in England using the OpenSAFELY platform.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00757.
PubMed
Abstract available
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A
prospective cohort study.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00748.
PubMed
Abstract available
COVID-19 vaccination coverage and intent among women aged 18-49 years by
pregnancy status, United States, April-November 2021.
Vaccine. 2022 Jun 13. pii: S0264-410X(22)00779.
PubMed
Abstract available
Benefit-risk evaluation of COVID-19 vaccination in special population groups of
interest.
Vaccine. 2022 May 27. pii: S0264-410X(22)00682.
PubMed
Abstract available
Dynamics of antibody titers and cellular immunity among Japanese healthcare
workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00763.
PubMed
Abstract available
Estimating the burden of adult hospitalized RSV infection including special
populations.
Vaccine. 2022;40:4121-4127.
PubMed
Abstract available
Influenza cases in nine aged care facilities in Sydney, Australia over a
three-year surveillance period, 2018-2020.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00476.
PubMed
Abstract available
Vaccine-associated attenuation of subjective severity among outpatients with
influenza.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00767.
PubMed
Abstract available
COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general
intelligence in a large, UK cohort.
Vaccine. 2022 May 27. pii: S0264-410X(22)00678.
PubMed
Abstract available
The effect of health literacy on COVID-19 vaccine hesitancy among community
population in China: The moderating role of stress.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00762.
PubMed
Abstract available
Immunophenotyping of SARS-CoV-2 and vaccine design.
Vaccine. 2022;40:3985-3986.
PubMed
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine
design.
Vaccine. 2022;40:3987-3988.
PubMed
Rubella antibodies in vertically and horizontally HIV-infected young adults
vaccinated early in life and response to a booster dose in those with
seronegative results.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00774.
PubMed
Abstract available
Clinical endpoints to inform vaccine policy: A systematic review of outcome
measures from pediatric influenza vaccine efficacy trials.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00778.
PubMed
Abstract available
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during
pregnancy.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00756.
PubMed
Abstract available
A quality improvement study: Optimizing pneumococcal vaccination rates in
children with cochlear implants.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00769.
PubMed
Abstract available
HA and M2 sequences alter the replication of 2013-16 H1 live attenuated influenza
vaccine infection in human nasal epithelial cell cultures.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00733.
PubMed
Abstract available
RelCoVax(R), a two antigen subunit protein vaccine candidate against SARS-CoV-2
induces strong immune responses in mice.
Vaccine. 2022 Jun 13. pii: S0264-410X(22)00775.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by